Cargando…
Synergistic Effect of Notch-3-Specific Inhibition and Paclitaxel in Non-Small Cell Lung Cancer (NSCLC) Cells Via Activation of The Intrinsic Apoptosis Pathway
BACKGROUND: Lung cancers are resistant to conventional chemotherapeutic interventions such as paclitaxel. Notch signaling is crucial in the chemoresistance of lung cancer cells. The Notch inhibitor gamma-secretase inhibitor (GSI) inhibits the Notch signaling pathway. MATERIAL/METHODS: Here, we evalu...
Autores principales: | He, Fenglian, Du, Ting, Jiang, Qian, Zhang, Yanbei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553439/ https://www.ncbi.nlm.nih.gov/pubmed/28769027 http://dx.doi.org/10.12659/MSM.902641 |
Ejemplares similares
-
Specific inhibitor of Notch-3 enhances the sensitivity of NSCLC cells to gemcitabine
por: Hu, Bi-Dan, et al.
Publicado: (2018) -
Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p
por: Tian, Lin-Juan, et al.
Publicado: (2019) -
Rhizoma Paridis Saponins Induces Cell Cycle Arrest and Apoptosis in Non-Small Cell Lung Carcinoma A549 Cells
por: Zhang, Jue, et al.
Publicado: (2015) -
Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line
por: Gu, Xi, et al.
Publicado: (2015) -
Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells
por: Xu, Yimiao, et al.
Publicado: (2011)